Shares of Jaguar Animal Health, Inc. (NASDAQ:JAGX) shot up 10.4% during trading on Friday . The company traded as high as $0.53 and last traded at $0.44, with a volume of 335,379 shares changing hands. The stock had previously closed at $0.49.

A number of research firms have commented on JAGX. HC Wainwright set a $2.00 price objective on shares of Jaguar Animal Health and gave the company a “buy” rating in a research note on Tuesday, July 11th. Rodman & Renshaw began coverage on shares of Jaguar Animal Health in a research note on Tuesday, July 11th. They set a “buy” rating and a $2.00 price objective for the company.

The company’s 50 day moving average price is $0.55 and its 200-day moving average price is $0.76. The stock’s market capitalization is $43.28 million.

TRADEMARK VIOLATION WARNING: This piece of content was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/26/jaguar-animal-health-inc-jagx-shares-up-10-4.html.

Jaguar Animal Health Company Profile

Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.